Search research articles
Contact Us
Filters
Showing results (51-60 of 193) with videos related to
Page
of 20
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
June 27, 2003
Negative correlation between therapeutic success in radioiodine therapy and TcTUs: are TcTUs-adapted dose concepts the only possible answer?
Martin Gotthardt, Miriam Nowack, Martin P Béhé, et al.
Clinical Nuclear Medicine
|
November 12, 2025
68 Ga-NODAGA-EXENDIN-4 PET/CT in the Detection or the Exclusion of Occult Sporadic Insulinomas
Cyrielle Aveline, Timofei Rusu, Françoise Montravers, et al.
Clinical Nuclear Medicine
|
September 15, 2010
Nodular fasciitis on F-18 FDG PET
Martin Gotthardt, Anne Arens, Erik van der Heijden, et al.
European Urology Focus
|
March 4, 2019
Modelling Study with an Interactive Model Assessing the Cost-effectiveness of <sup>68</sup>Ga Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Nano Magnetic Resonance Imaging for the Detection of Pelvic Lymph Node Metastases in Patients with Primary Prostate Cancer
Mirre Scholte, Jelle O Barentsz, J P Michiel Sedelaar, et al.
BMJ Open
|
August 23, 2022
CXCR4-directed [<sup>68</sup>Ga]Ga-PentixaFor PET/CT versus adrenal vein sampling performance: a study protocol for a randomised two-step controlled diagnoStic Trial Ultimately comparing hypertenSion outcome in primary aldosteronism (CASTUS)
Amir Hossein Chaman Baz, Elle van de Wiel, Hans Groenewoud, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 2, 2022
Reply: <sup>68</sup>Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
Vikas Prasad, Marti Boss, Christof Rottenburger, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 29, 2022
Conjugation to a cell-penetrating peptide drives the tumour accumulation of the GLP1R antagonist exendin(9-39)
Estel Collado Camps, Sanne A M van Lith, Annemarie Kip, et al.
Clinical Nuclear Medicine
|
November 16, 2016
Imaging of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-HBED-CC-PSMA PET/CT
Susanne Lütje, Benedikt Gomez, Joseph Cohnen, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 2, 2021
CPPs to the Test: Effects on Binding, Uptake and Biodistribution of a Tumor Targeting Nanobody
Estel Collado Camps, Sanne A M van Lith, Cathelijne Frielink, et al.
Molecular Imaging and Biology
|
February 18, 2016
Strain Differences Determine the Suitability of Animal Models for Noninvasive In Vivo Beta Cell Mass Determination with Radiolabeled Exendin
Stefanie M A Willekens, Lieke Joosten, Otto C Boerman, et al.
Page
of 20
Search research articles
Search
Showing results (51-60 of 193) with videos related to
Sort By:
Page
of 20
European Journal of Nuclear Medicine and Molecular Imaging
|
June 27, 2003
Negative correlation between therapeutic success in radioiodine therapy and TcTUs: are TcTUs-adapted dose concepts the only possible answer?
Martin Gotthardt, Miriam Nowack, Martin P Béhé, et al.
Clinical Nuclear Medicine
|
November 12, 2025
68 Ga-NODAGA-EXENDIN-4 PET/CT in the Detection or the Exclusion of Occult Sporadic Insulinomas
Cyrielle Aveline, Timofei Rusu, Françoise Montravers, et al.
Clinical Nuclear Medicine
|
September 15, 2010
Nodular fasciitis on F-18 FDG PET
Martin Gotthardt, Anne Arens, Erik van der Heijden, et al.
European Urology Focus
|
March 4, 2019
Modelling Study with an Interactive Model Assessing the Cost-effectiveness of <sup>68</sup>Ga Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Nano Magnetic Resonance Imaging for the Detection of Pelvic Lymph Node Metastases in Patients with Primary Prostate Cancer
Mirre Scholte, Jelle O Barentsz, J P Michiel Sedelaar, et al.
BMJ Open
|
August 23, 2022
CXCR4-directed [<sup>68</sup>Ga]Ga-PentixaFor PET/CT versus adrenal vein sampling performance: a study protocol for a randomised two-step controlled diagnoStic Trial Ultimately comparing hypertenSion outcome in primary aldosteronism (CASTUS)
Amir Hossein Chaman Baz, Elle van de Wiel, Hans Groenewoud, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 2, 2022
Reply: <sup>68</sup>Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
Vikas Prasad, Marti Boss, Christof Rottenburger, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 29, 2022
Conjugation to a cell-penetrating peptide drives the tumour accumulation of the GLP1R antagonist exendin(9-39)
Estel Collado Camps, Sanne A M van Lith, Annemarie Kip, et al.
Clinical Nuclear Medicine
|
November 16, 2016
Imaging of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-HBED-CC-PSMA PET/CT
Susanne Lütje, Benedikt Gomez, Joseph Cohnen, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 2, 2021
CPPs to the Test: Effects on Binding, Uptake and Biodistribution of a Tumor Targeting Nanobody
Estel Collado Camps, Sanne A M van Lith, Cathelijne Frielink, et al.
Molecular Imaging and Biology
|
February 18, 2016
Strain Differences Determine the Suitability of Animal Models for Noninvasive In Vivo Beta Cell Mass Determination with Radiolabeled Exendin
Stefanie M A Willekens, Lieke Joosten, Otto C Boerman, et al.
Page
of 20